Publicaciones en colaboración con investigadores/as de Karolinska Institute (21)

2022

  1. Defects of Nutrient Signaling and Autophagy in Neurodegeneration

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Nature Communications, Vol. 12, Núm. 1

2018

  1. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

2017

  1. Aggregation of the inflammatory s100a8 precedes a? plaque formation in transgenic app mice: Positive feedback for s100a8 and a? productions

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 72, Núm. 3, pp. 319-328

  2. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis

    Expert Reviews in Molecular Medicine, Vol. 19

  3. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. ALS: A bucket of genes, environment, metabolism and unknown ingredients

    Progress in Neurobiology, Vol. 142, pp. 104-129

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  2. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482

  3. Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: A randomized controlled trial

    International Journal of Sports Medicine, Vol. 36, Núm. 1, pp. 54-60

2012

  1. Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and Arc levels and impairs memory in young mice

    Journal of Alzheimer's Disease, Vol. 32, Núm. 2, pp. 341-355

  2. Corrigendum to "Estrogen protects against amyloid-β toxicity by estrogen receptor α-mediated inhibition of Daxx translocation" [Neurosci. Lett. 506 (2011) 245-250]

    Neuroscience Letters

  3. Estrogen protects against amyloid-β toxicity by estrogen receptor α-mediated inhibition of Daxx translocation

    Neuroscience Letters, Vol. 506, Núm. 2, pp. 245-250

  4. Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain

    EMBO Molecular Medicine, Vol. 4, Núm. 10, pp. 1097-1111

2011

  1. Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease

    Electrophoresis, Vol. 32, Núm. 19, pp. 2757-2764

  2. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF down regulation

    Hippocampus, Vol. 21, Núm. 9, pp. 999-1009

  3. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism

    Journal of Biological Chemistry, Vol. 286, Núm. 29, pp. 25574-25585

  4. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 24, Núm. 4, pp. 669-679

2010

  1. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 829-838

  2. Insulin levels are decreased in the cerebrospinal fluid of women with prodomal alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 2, pp. 405-413